SHS stands for life science and medical technology investments.

For more than 25 years.

Our investment focus

From growth to medium-sized companies: We invest in fast-growing companies in the life science and medical technology sector.

Our portfolio

From cardiology to digital health: Our portfolio currently comprises more than 20 companies from the various life science and medical technology sub sectors.

Our investors

From pension funds to family offices: For many years partners have entrusted us with their capital in order to achieve attractive returns on it.

We invest in European healthcare champions


Experience for more
than 25 years

Since its foundation in 1993, SHS has been investing in innovative companies in the life science and medical technology sectors.

With our investments, we help shape European champions in their respective healthcare segments or support them in their further expansion.

In addition to capital, we essentially provide our networks and expertise in the areas of approval and reimbursement in the USA and China, marketing/sales, staffing and exit.

SHS in figures


Years of history


Fund generations




Million €
current fund volume


Million €


Transactions assessments p.a.

Latest News

16 May 2022 - Press Releases

MEDTECH-INSIDE – Part 16: Germany leads in DiGA

9 May 2022 - SHS News

SHS strengthens finance team: Lukas Maucher joins Tübingen-based private equity investor as CFO

22 April 2022 - SHS News

SHS and yabeo invest in the leading Scandinavian digital health platform Dr.Dropin